Article(id=1330225982176342394, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.07.022, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1651161600000, receivedDateStr=2022-04-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080188554, onlineDateStr=2026-11-19, pubDate=1657382400000, pubDateStr=2022-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080188554, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080188554, creator=13701087609, updateTime=1795080188554, updator=13701087609, issue=Issue{id=1330225816673301282, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='7', pageStart='815', pageEnd='956', issueExtLink='null', onlineDate='null', pubDate='1657382400000', pubDateStr='2022-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080149094, creator='13701087609', updateTime=1795084753930, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245131388695240, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245131388695241, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=939, endPage=945, ext={EN=ArticleExt(id=1330225982365086075, articleId=1330225982176342394, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress on Chinese and western medicine for the treatment of corona virus disease 2019, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are spreading globally on a large scale, threatening the safety of human life seriously, and the world needs effective drugs against COVID-19 urgently. Recently, four oral small molecule drugs have been successfully approved for market to treat patients with early mild COVID-19, they were 3C-like protease (3CLpro) inhibitor, RNA-dependent RNA polymerase (RdRp) inhibitor, monoclonal antibody, androgen receptor inhibitor. This paper briefly summarizes these four types of drugs and reviews their clinical therapeutic effects, characteristics and mechanism of action, to provide some references for the development and usage of drugs for the treatment of COVID-19.

, authors=Siriguleng1, Huanhuan LIU1, 2, Wurihan1, Xiaobin GUO1, Hongxin YANG1, *, authorsList=Siriguleng, Huanhuan LIU, Wurihan, Xiaobin GUO, Hongxin YANG, authorCompany=null, correspAuthors=Hongxin YANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225982578995580, articleId=1330225982176342394, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=新型冠状病毒肺炎中西药物治疗的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

新型冠状病毒(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)引发的急性呼吸道传染性疾病在全球大规模流行,严重威胁人类生命安全,全世界迫切需要安全、有效的SARS-CoV-2肺炎(corona virus disease 2019,COVID-19)治疗及预防药物。目前,主要开发的特效药物有以下4类:3CL蛋白酶(3C-like protease,3CLpro)抑制剂、RNA依赖的RNA聚合酶(RNA-dependent RNA polymerase,RdRp)抑制剂、单克隆抗体及雄激素受体抑制剂,用于治疗早期轻症COVID-19患者。本文主要梳理此4类药物,并总结其临床治疗效果、作用特点及机制,以期为COVID-19的有效药物开发及使用提供一定参考。

, authors=斯日古楞1, 刘欢欢1, 2, 乌日汗1, 郭小彬1, 杨宏昕1, *, authorsList=斯日古楞, 刘欢欢, 乌日汗, 郭小彬, 杨宏昕, authorCompany=null, correspAuthors=杨宏昕, authorNote=

斯日古楞,副主任药师,研究方向:临床药学。

, correspAuthorsNote=
杨宏昕,主任药师,研究方向:医院药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=06VOvt9pjh0R56IRL+mPNQ==, magXml=wPMPd9TrfCpqC6t7tf/ZMw==, pdfUrl=null, pdf=+8M0LyKK2SSh627h7MQEuQ==, pdfFileSize=2332511, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=hemehRl5bCC7NoLazHlB9A==, mapNumber=null, fund=null)}, authors=[Author(id=1330225982910345606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225982981648776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225982910345606, language=EN, stringName=Siriguleng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983065534857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225982910345606, language=CN, stringName=斯日古楞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio={"content":"

斯日古楞,副主任药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

斯日古楞,副主任药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983120060811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983195558286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983120060811, language=EN, stringName=Huanhuan LIU, firstName=Huanhuan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China
2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983262667151, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983120060811, language=CN, stringName=刘欢欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017
2.包头医学院研究生院,内蒙古 包头 014060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)]), AuthorCompany(id=1330225982834848128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=2., ext=[AuthorCompanyExt(id=1330225982843236738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982851625347, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.包头医学院研究生院,内蒙古 包头 014060)])]), Author(id=1330225983338164625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983409467795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983338164625, language=EN, stringName=Wurihan, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983472382356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983338164625, language=CN, stringName=乌日汗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983539491222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983627571608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983539491222, language=EN, stringName=Xiaobin GUO, firstName=Xiaobin, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983694680473, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983539491222, language=CN, stringName=郭小彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983765983643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225983849869725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983765983643, language=EN, stringName=Hongxin YANG, firstName=Hongxin, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983925367198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983765983643, language=CN, stringName=杨宏昕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])])], keywords=[Keyword(id=1330225984030224799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=1, keyword=severe acute respiratory syndrome coronavirus 2), Keyword(id=1330225984084750754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=2, keyword=corona virus disease 2019), Keyword(id=1330225984160248226, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=3, keyword=oral small molecule drugs), Keyword(id=1330225984214774179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=4, keyword=traditional Chinese medicine), Keyword(id=1330225984277688740, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=5, keyword=clinical trials), Keyword(id=1330225984340603301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=EN, orderNo=6, keyword=drug development), Keyword(id=1330225984407712166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=1, keyword=新型冠状病毒), Keyword(id=1330225984516764071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=2, keyword=新型冠状病毒肺炎), Keyword(id=1330225984583872936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=3, keyword=小分子口服药物), Keyword(id=1330225984646787497, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=4, keyword=中医药), Keyword(id=1330225984722284970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=5, keyword=临床研究), Keyword(id=1330225984797782443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, language=CN, orderNo=6, keyword=药物研发)], refs=[Reference(id=1330225985003303343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273., articleTitle=null, refAbstract=null), Reference(id=1330225985070412208, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=国家卫生健康委员会. 关于修订新型冠状病毒肺炎英文命名事宜的通知〔国卫医函(202070)号〕[EB/OL]. (2020-02-22) [2021-12-27]. http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml., articleTitle=null, refAbstract=null), Reference(id=1330225985129132465, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=University JH. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU)[EB/OL]. (2022-01-06) [2022-01-06]. https://coronavirus.jhu.edu/map.Html., articleTitle=null, refAbstract=null), Reference(id=1330225985192047026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Fung TS, Liu DX. Human coronavirus: host-pathogen interaction[J]. Annu Rev Microbiol, 2019, 73: 529-557., articleTitle=null, refAbstract=null), Reference(id=1330225985250767283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen N, Zhang B, Deng L, et al. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2[J]. Emerg Microbes Infect, 2022, 11(1): 1371-1389., articleTitle=null, refAbstract=null), Reference(id=1330225985334653364, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Fan K, Ma L, Han X, et al. The substrate specificity of SARS coronavirus 3C-like proteinase[J]. Biochem Biophys Res Commun, 2005, 329(3): 934-940., articleTitle=null, refAbstract=null), Reference(id=1330225985405956533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases[J]. PLoS Biol, 2005, 3(10): e324., articleTitle=null, refAbstract=null), Reference(id=1330225985468871094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs[J]. Science, 2003, 300(5626): 1763-1767., articleTitle=null, refAbstract=null), Reference(id=1330225985535979959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Dragovich PS, Prins TJ, Zhou R, et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors 4 incorporation of P1 lactam moieties as L-glutamine replacements[J]. J Med Chem, 1999, 42(7): 1213-1224., articleTitle=null, refAbstract=null), Reference(id=1330225985603088824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Owen DR, Allerton CMN, Anderson AS, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19[J]. Science, 2021, 374(6575): 1586-1593., articleTitle=null, refAbstract=null), Reference(id=1330225985666003385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Vangeel L, Chiu W, De Jonghe S, et al. Remdesivir, molnupiravir and nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern[J]. Antiviral Res, 2022, 198: 105252., articleTitle=null, refAbstract=null), Reference(id=1330225985733112250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ClinicalTrials. gov. 12 Studies found for: PF-07321332[EB/OL]. (2022-02-12) [2022-02-12]. https://www.clinicaltrials.gov/ct2/results?cond=&term=PF-07321332&cntry=&state=&city=&dist=., articleTitle=null, refAbstract=null), Reference(id=1330225985791832507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Pfizer Inc. Pfizer announces additional phase 2/3 study results confirming robust efficacy of novel COVID-19 oral antiviral treatment candidate in reducing risk of hospitalization or death[EB/OL]. (2021-12-14) [2022-02-12]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announcesadditional-phase-23-study-results., articleTitle=null, refAbstract=null), Reference(id=1330225985863135676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infect, 2020, 9(1): 221-236., articleTitle=null, refAbstract=null), Reference(id=1330225985921855933, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Sheahan TP, Sims AC, Zhou S, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice[J]. Sci Transl Med, 2020, 12(541): eabb5883., articleTitle=null, refAbstract=null), Reference(id=1330225986039296446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis[J]. Nat Struct Mol Biol, 2021, 28(9): 740-746., articleTitle=null, refAbstract=null), Reference(id=1330225986110599615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020, 30(3): 269-271., articleTitle=null, refAbstract=null), Reference(id=1330225986194485696, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients[J]. N Engl J Med, 2022, 386(6): 509-520., articleTitle=null, refAbstract=null), Reference(id=1330225986253205953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Merck. Merck and Ridgeback's Molnupiravir Receives U. S. FDA emergency use authorization for the treatment of high-risk adults with mild to moderate COVID-19[EB/OL]. (2021-11-23) [2022-01-06]. https://www.merck.com/news/merck-and-ridgebacks-molnupiravir-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-high-risk-adults-with-mild-to-moderateCOVID-19/., articleTitle=null, refAbstract=null), Reference(id=1330225986316120514, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Willyard C. How antiviral pill molnupiravir shot ahead in the COVID drug hunt[EB/OL]. (2021-10-10) [2022-01-06]. https://www.nature.com/articles/d41586-021-02783-1., articleTitle=null, refAbstract=null), Reference(id=1330225986379035075, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 国家药监局应急批准腾盛华创医药技术(北京)有限公司新冠病毒中和抗体联合治疗药物安巴韦单抗注射液(BRII-196)及罗米司韦单抗注射液(BRII-198)注册申请[EB/OL] (2021-12-08) [2022-01-06]. https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html., articleTitle=null, refAbstract=null), Reference(id=1330225986433561028, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Brii B. Brii Bio initiates submission of emergency use authorization filing to U. S. FDA for BRII-196/BRII-198, its monoclonal sntibody Combination therapy for non-hospitalized COVID-19 patients at high tisk of clinical progression to severe disease[EB/OL]. (2021-10-09) [2022-01-06]. http://www.briibio.com/news-detial.php?id=370#news., articleTitle=null, refAbstract=null), Reference(id=1330225986492281285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Cadegiani FA, McCoy J, Gustavo Wambier C, et al. Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial[J]. Cureus, 2021, 13(2): e13492., articleTitle=null, refAbstract=null), Reference(id=1330225986551001542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=开拓药业. 开拓药业公布普克鲁胺治疗轻中症新冠患者Ⅲ期临床试验中期分析进展[EB/OL]. (2021-12-27) [2021-12-30]. https://www.kintor.com.cn/news/246.html., articleTitle=null, refAbstract=null), Reference(id=1330225986605527495, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=World Health Organization. WHO coronavirus (COVID-19) dashboard[EB/OL]. (2022-01-06) [2022-01-06]. https://covid19.who.int/., articleTitle=null, refAbstract=null), Reference(id=1330225986672636360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial[J]. Phytomedicine, 2021, 85: 153242., articleTitle=null, refAbstract=null), Reference(id=1330225986727162313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Gong X, Yuan B, Yuan Y, et al. Efficacy and safety of Lianhuaqingwen capsules for the prevention of coronavirus disease 2019: a prospective open-label controlled trial[J]. Evid Based Complement Alternat Med, 2021, 2021: 7962630., articleTitle=null, refAbstract=null), Reference(id=1330225986781688266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu C, He B, Gong F, et al. The adverse reactions of lianhua qingwen capsule/granule compared with conventional drug in clinical application: a meta-analysis[J]. Front Pharmacol, 2022, 13: 764774., articleTitle=null, refAbstract=null), Reference(id=1330225986852991435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo H, Zheng J, Huang G, et al. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study[J]. Ann Palliat Med, 2020, 9(5): 3235–3248., articleTitle=null, refAbstract=null), Reference(id=1330225986907517388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma Q, Qiu M, Zhou H, et al. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical corona virus disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2[J]. Pharmacol Res, 2020, 160: 105073., articleTitle=null, refAbstract=null), Reference(id=1330225986966237645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=刘学松, 宋元林, 关伟杰, 等. 血必净注射液治疗重症新型冠状病毒肺炎的多中心前瞻性队列研究[J]. 中华危重病急救医学, 2021, 33(7): 774-778., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225984911028652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, awardId=201701, language=CN, fundingSource=内蒙古自治区人民医院院内项目(201701), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)]), AuthorCompany(id=1330225982834848128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=2., ext=[AuthorCompanyExt(id=1330225982843236738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982851625347, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.包头医学院研究生院,内蒙古 包头 014060)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.022, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.022, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.07.022, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.07.022, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1657382400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
新型冠状病毒肺炎中西药物治疗的研究进展
斯日古楞 1 , 刘欢欢 1, 2 , 乌日汗 1 , 郭小彬 1 , 杨宏昕 1, *
世界临床药物 | 综述评论 2022,43(7): 939-945
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (7) : 939 -945
新型冠状病毒肺炎中西药物治疗的研究进展
全屏
[Author(id=1330225982910345606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225982981648776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225982910345606, language=EN, stringName=Siriguleng, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983065534857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225982910345606, language=CN, stringName=斯日古楞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio={"content":"

斯日古楞,副主任药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

斯日古楞,副主任药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983120060811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983195558286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983120060811, language=EN, stringName=Huanhuan LIU, firstName=Huanhuan, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China
2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983262667151, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983120060811, language=CN, stringName=刘欢欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017
2.包头医学院研究生院,内蒙古 包头 014060, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)]), AuthorCompany(id=1330225982834848128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=2., ext=[AuthorCompanyExt(id=1330225982843236738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982851625347, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982834848128, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.包头医学院研究生院,内蒙古 包头 014060)])]), Author(id=1330225983338164625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983409467795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983338164625, language=EN, stringName=Wurihan, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983472382356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983338164625, language=CN, stringName=乌日汗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983539491222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225983627571608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983539491222, language=EN, stringName=Xiaobin GUO, firstName=Xiaobin, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983694680473, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983539491222, language=CN, stringName=郭小彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1330225983765983643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225983849869725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983765983643, language=EN, stringName=Hongxin YANG, firstName=Hongxin, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225983925367198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, authorId=1330225983765983643, language=CN, stringName=杨宏昕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225982755156349, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, xref=1., ext=[AuthorCompanyExt(id=1330225982763544958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China), AuthorCompanyExt(id=1330225982771933567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225982176342394, companyId=1330225982755156349, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])])]
斯日古楞1, 刘欢欢1, 2, 乌日汗1, 郭小彬1, 杨宏昕1, *
作者信息
  • 1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017
  • 2.包头医学院研究生院,内蒙古 包头 014060
通讯作者:
杨宏昕,主任药师,研究方向:医院药学。
作者简介:

斯日古楞,副主任药师,研究方向:临床药学。

Progress on Chinese and western medicine for the treatment of corona virus disease 2019
Siriguleng1, Huanhuan LIU1, 2, Wurihan1, Xiaobin GUO1, Hongxin YANG1, *
Affiliations
  • 1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China
  • 2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China
出版时间: 2022-07-10 doi: 10.13683/j.wph.2022.07.022
文章导航
收藏切换

新型冠状病毒(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)引发的急性呼吸道传染性疾病在全球大规模流行,严重威胁人类生命安全,全世界迫切需要安全、有效的SARS-CoV-2肺炎(corona virus disease 2019,COVID-19)治疗及预防药物。目前,主要开发的特效药物有以下4类:3CL蛋白酶(3C-like protease,3CLpro)抑制剂、RNA依赖的RNA聚合酶(RNA-dependent RNA polymerase,RdRp)抑制剂、单克隆抗体及雄激素受体抑制剂,用于治疗早期轻症COVID-19患者。本文主要梳理此4类药物,并总结其临床治疗效果、作用特点及机制,以期为COVID-19的有效药物开发及使用提供一定参考。

新型冠状病毒  /  新型冠状病毒肺炎  /  小分子口服药物  /  中医药  /  临床研究  /  药物研发

Corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are spreading globally on a large scale, threatening the safety of human life seriously, and the world needs effective drugs against COVID-19 urgently. Recently, four oral small molecule drugs have been successfully approved for market to treat patients with early mild COVID-19, they were 3C-like protease (3CLpro) inhibitor, RNA-dependent RNA polymerase (RdRp) inhibitor, monoclonal antibody, androgen receptor inhibitor. This paper briefly summarizes these four types of drugs and reviews their clinical therapeutic effects, characteristics and mechanism of action, to provide some references for the development and usage of drugs for the treatment of COVID-19.

severe acute respiratory syndrome coronavirus 2  /  corona virus disease 2019  /  oral small molecule drugs  /  traditional Chinese medicine  /  clinical trials  /  drug development
斯日古楞, 刘欢欢, 乌日汗, 郭小彬, 杨宏昕. 新型冠状病毒肺炎中西药物治疗的研究进展. 世界临床药物, 2022 , 43 (7) : 939 -945 . DOI: 10.13683/j.wph.2022.07.022
Siriguleng, Huanhuan LIU, Wurihan, Xiaobin GUO, Hongxin YANG. Progress on Chinese and western medicine for the treatment of corona virus disease 2019[J]. World Clinical Drug, 2022 , 43 (7) : 939 -945 . DOI: 10.13683/j.wph.2022.07.022
  • 内蒙古自治区人民医院院内项目(201701)
参考文献 引证文献
排序方式:
[1]
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273.
[2]
国家卫生健康委员会. 关于修订新型冠状病毒肺炎英文命名事宜的通知〔国卫医函(202070)号〕[EB/OL]. (2020-02-22) [2021-12-27]. http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml.
[3]
University JH. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU)[EB/OL]. (2022-01-06) [2022-01-06]. https://coronavirus.jhu.edu/map.Html.
[4]
Fung TS, Liu DX. Human coronavirus: host-pathogen interaction[J]. Annu Rev Microbiol, 2019, 73: 529-557.
[5]
Chen N, Zhang B, Deng L, et al. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2[J]. Emerg Microbes Infect, 2022, 11(1): 1371-1389.
[6]
Fan K, Ma L, Han X, et al. The substrate specificity of SARS coronavirus 3C-like proteinase[J]. Biochem Biophys Res Commun, 2005, 329(3): 934-940.
[7]
Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases[J]. PLoS Biol, 2005, 3(10): e324.
[8]
Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs[J]. Science, 2003, 300(5626): 1763-1767.
[9]
Dragovich PS, Prins TJ, Zhou R, et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors 4 incorporation of P1 lactam moieties as L-glutamine replacements[J]. J Med Chem, 1999, 42(7): 1213-1224.
[10]
Owen DR, Allerton CMN, Anderson AS, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19[J]. Science, 2021, 374(6575): 1586-1593.
[11]
Vangeel L, Chiu W, De Jonghe S, et al. Remdesivir, molnupiravir and nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern[J]. Antiviral Res, 2022, 198: 105252.
[12]
ClinicalTrials. gov. 12 Studies found for: PF-07321332[EB/OL]. (2022-02-12) [2022-02-12]. https://www.clinicaltrials.gov/ct2/results?cond=&term=PF-07321332&cntry=&state=&city=&dist=.
[13]
Pfizer Inc. Pfizer announces additional phase 2/3 study results confirming robust efficacy of novel COVID-19 oral antiviral treatment candidate in reducing risk of hospitalization or death[EB/OL]. (2021-12-14) [2022-02-12]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announcesadditional-phase-23-study-results.
[14]
Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infect, 2020, 9(1): 221-236.
[15]
Sheahan TP, Sims AC, Zhou S, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice[J]. Sci Transl Med, 2020, 12(541): eabb5883.
[16]
Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis[J]. Nat Struct Mol Biol, 2021, 28(9): 740-746.
[17]
Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020, 30(3): 269-271.
[18]
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients[J]. N Engl J Med, 2022, 386(6): 509-520.
[19]
Merck. Merck and Ridgeback's Molnupiravir Receives U. S. FDA emergency use authorization for the treatment of high-risk adults with mild to moderate COVID-19[EB/OL]. (2021-11-23) [2022-01-06]. https://www.merck.com/news/merck-and-ridgebacks-molnupiravir-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-high-risk-adults-with-mild-to-moderateCOVID-19/.
[20]
Willyard C. How antiviral pill molnupiravir shot ahead in the COVID drug hunt[EB/OL]. (2021-10-10) [2022-01-06]. https://www.nature.com/articles/d41586-021-02783-1.
[21]
国家药品监督管理局. 国家药监局应急批准腾盛华创医药技术(北京)有限公司新冠病毒中和抗体联合治疗药物安巴韦单抗注射液(BRII-196)及罗米司韦单抗注射液(BRII-198)注册申请[EB/OL] (2021-12-08) [2022-01-06]. https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html.
[22]
Brii B. Brii Bio initiates submission of emergency use authorization filing to U. S. FDA for BRII-196/BRII-198, its monoclonal sntibody Combination therapy for non-hospitalized COVID-19 patients at high tisk of clinical progression to severe disease[EB/OL]. (2021-10-09) [2022-01-06]. http://www.briibio.com/news-detial.php?id=370#news.
[23]
Cadegiani FA, McCoy J, Gustavo Wambier C, et al. Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial[J]. Cureus, 2021, 13(2): e13492.
[24]
开拓药业. 开拓药业公布普克鲁胺治疗轻中症新冠患者Ⅲ期临床试验中期分析进展[EB/OL]. (2021-12-27) [2021-12-30]. https://www.kintor.com.cn/news/246.html.
[25]
World Health Organization. WHO coronavirus (COVID-19) dashboard[EB/OL]. (2022-01-06) [2022-01-06]. https://covid19.who.int/.
[26]
Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial[J]. Phytomedicine, 2021, 85: 153242.
[27]
Gong X, Yuan B, Yuan Y, et al. Efficacy and safety of Lianhuaqingwen capsules for the prevention of coronavirus disease 2019: a prospective open-label controlled trial[J]. Evid Based Complement Alternat Med, 2021, 2021: 7962630.
[28]
Hu C, He B, Gong F, et al. The adverse reactions of lianhua qingwen capsule/granule compared with conventional drug in clinical application: a meta-analysis[J]. Front Pharmacol, 2022, 13: 764774.
[29]
Guo H, Zheng J, Huang G, et al. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study[J]. Ann Palliat Med, 2020, 9(5): 3235–3248.
[30]
Ma Q, Qiu M, Zhou H, et al. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical corona virus disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2[J]. Pharmacol Res, 2020, 160: 105073.
[31]
刘学松, 宋元林, 关伟杰, 等. 血必净注射液治疗重症新型冠状病毒肺炎的多中心前瞻性队列研究[J]. 中华危重病急救医学, 2021, 33(7): 774-778.
2022年第43卷第7期
11
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.07.022
  • 接收时间:2022-04-29
  • 首发时间:2026-11-19
  • 出版时间:2022-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-04-29
基金
内蒙古自治区人民医院院内项目(201701)
作者信息
    1.内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017
    2.包头医学院研究生院,内蒙古 包头 014060

通讯作者:

杨宏昕,主任药师,研究方向:医院药学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.022
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏